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Homozygous Missense Mutation in Fibulin-5
in an Iranian Autosomal Recessive Cutis Laxa
Pedigree and Associated Haplotype
Elahe Elahi1,2, Reza Kalhor1,3, Setareh S. Banihosseini1,4, Noorossadat Torabi1,3, Hamid Pour-Jafari5,
Massoud Houshmand1, Seyed S.H. Amini6, Ahmad Ramezani7 and Bart Loeys8
Cutis laxa is a rare group of inherited and acquired disorders characterized by loose and redundant skin with
reduced elasticity. Mutations in the elastin coding gene have been shown to cause autosomal dominant cutis
laxa in three families. A homozygous mutation in the fibulin-5 coding gene was discovered in a Turkish pedigree
showing recessive inheritance, and a different mutation in this gene was found in the heterozygous state in a
sporadic case of the disease. Here, we report the third case of a mutation in the fibulin-5 coding gene in a
recessive Iranian cutis laxa pedigree. The mutation is the same as previously reported in the Turkish pedigree,
further confirming that it is causative of disease. A haplotype consisting of seven intragenic sequence variations
common to both pedigrees is described for the mutation-carrying fibulin-5 allele.
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INTRODUCTION
Cutis laxa is a heterogeneous group of rare inherited and
acquired connective tissue disorders, whose common feature
is occurrence of loose and redundant skin with decreased
elasticity (Uitto and Pulkkinen, 2002). This phenotype and
other characteristics are ultimately due to fragmentation and
paucity of elastic fibers (Hashimoto and Kanzaki, 1975;
Kitano et al., 1989). Hereditary cutis laxa is inherited in both
autosomal dominant and autosomal recessive modes (Beighton,
1972; Agha et al., 1978). Autosomal dominant cutis laxa
(OMIM 123700) is relatively benign, and has been shown in
three families to be due to mutations in the elastin coding
gene (ELN) (Tassabehji et al., 1998; Zhang et al., 1999). Three
types of autosomal recessive cutis laxa with distinct
phenotypic features have been described (Agha et al.,
1978; Genevieve et al., 2004). Autosomal recessive type I
cutis laxa (OMIM 219100) shows the most severe
phenotype and has the poorest prognosis. In addition to the
skin, internal organs enriched in elastic fibers, such as the
lung and arteries, are affected. In 2002, it was reported
that a homozygous missense mutation in the FBLN5 gene
coding fibulin-5 was responsible for cutis laxa type I in a large
Turkish pedigree (Loeys et al., 2002). FBLN5 was considered
a strong candidate gene because the phenotypic abnormali-
ties observed in fibulin-5 knockout mouse models were
very similar to those associated with autosomal recessive
cutis laxa type I (Nakamura et al., 2002; Yanagisawa et al.,
2002). Fibulin-5 is an integrin ligand with six EGF-like
domains. In adults it is found mainly in tissues that contain
abundant elastic fibers, including the lung and the skin.
The mutation found in the Turkish family was deemed
disease-causing because of segregation with the disease
phenotype, absence among healthy individuals of the
population, conservation of the coded amino acid across
species and across other human fibulins, and predicted
structural and functional consequences on the protein
(Loeys et al., 2002). After this initial report, a tandem 22 kb
duplication within the FBLN5 gene in the heterozygous
state was reported in a sporadic case of cutis laxa (Markova
et al., 2003). It was shown that the mutated fibulin-5 mRNA
and protein were overexpressed compared to wild-type
forms, suggesting a transcriptional, processing, and/or stabi-
lity effect on the mRNA and thus accounting for the
dominant-negative effect of this mutation. The missense
mutation in the Turkish pedigree was suggested to affect
protein folding and cause instability, thus precluding the
dominant-negative effect in carriers. Four cutis laxa patients
have been found not to have mutations in the fibulin-5 or
elastin coding genes, suggesting further genetic heterogeneity
of the disease (Markova et al., 2003). In this investigation, we
sought disease-causing mutations in an Iranian cutis laxa
pedigree.
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RESULTS
Size analysis of FBLN5 proximal microsatellite markers in
the proband and her parents was consistent with linkage of
the cutis laxa phenotype with FBLN5 (not shown). Linkage to
ELN consistent with recessive inheritance was not observed
(not shown). As such, each of the exons and flanking
intronic sequences of FBLN5 were amplified and sequenced.
The proband carried a homozygous n.679T4C mutation in
exon 7 of the FBLN5 gene (nucleotide numbering uses
the convention wherein A of ATG start codon in cDNA is
annotated as nucleotide þ1), resulting in a serine to proline
substitution (p.S227P) in the fourth EGF-like domain of
fibulin-5 protein (Figure 1). This is the same mutation as
previously reported in the Turkish autosomal recessive
cutis laxa pedigree (Loeys et al., 2002). (The mutation in
the Turkish pedigree was reported as T998C in exon 5,
causing amino-acid substitution S227P. The authors of the
article have reported in a personal communication that the
mutation was misnumbered and was in fact the same
n.679T4C alteration reported here.) After identification of
the mutation in the proband, exon 7 was sequenced in her
parents (IV: 1, IV: 2), maternal grandfather (III: 2) and paternal
grandfather (III: 3), who were brothers, and an unaffected
sibling (V: 3) (Figure 2). The parents and grandparents all
carried the same mutation in the heterozygous state,
indicating that the mutation had been stable through at
least eight meiotic events. Both alleles of the unaffected
sibling were wild type. The n.679T4C nucleotide change
creates a HaeIII restriction enzyme recognition site. HaeIII
digestion of PCR-amplified exon 7 amplicons indicated
the absence of the site in the DNA of 50 control individuals
from the North-West region of Iran, which includes Hamadan
(not shown).
In addition to the putative disease-causing mutation,
the DNA of the proband showed seven additional
sequence variations as compared to the FBLN5 genomic
sequence NT_026437. One variation caused a synonymous
codon change and six were intronic. The variation that
caused a synonymous change was n.945T4C (rs2430347) in
exon 9, which changed the coding of isoleucine 315
from ATT to ATC. The first intronic variation was
IVS9þ 137delGTGTGTGT in intron 9, which caused a
change in the number of a two-nucleotide repeat
(17GT413GT). The second, third, and fourth intronic
variations, IVS9þ154G4A, IVS9þ 167T4G (rs7148155),
and IVS9-218A4G (rs2430342), were also in intron 9. The
remaining two intronic variations, IVS10þ68G4A
(rs2430341) and IVS10-45A4G (rs929608), were both in
intron 10. The first three intron 9 variations were all within a
sequence of tandem GT repeats. The sequence after
IVS9þ 137 in the reference sequence was 50-GTGTGTGTGT
GTGTGTGTGTGTGTGTGTGTGTGT-30 and the sequence in
the proband’s DNA was 50-GTGTGTGTATGTGTGTGTGTG
GGTGT-30. (This set of three changes is indicated by
XIVS9þ 137 in the haplotype in the Discussion.) All the
variations were homozygous in the proband. None of these
variations were predicted to affect splicing. All FBLN5
sequence variations found in the DNA of the proband of
the Iranian pedigree were also found in the homozygous state
upon sequencing of genomic DNA of an affected member of
the previously reported Turkish pedigree.
DISCUSSION
This is only the third report of a disease-causing mutation in
FBLN5 in a cutis laxa patient. The mutation reported here,
n.679T4C in exon 7 (S227P), was the same as the one
previously reported in a Turkish pedigree, and the inheritance
pattern of the disease in both families carrying the mutation
was autosomal recessive. The finding of the variation in our
pedigree and its absence in 50 Iranian control individuals
further strengthens the original authors’ arguments that the
S227P alteration in fibulin-5 protein can cause cutis laxa.
Recently, it was reported that sequence variations in FBLN5
may be involved in age-related macular degeneration (Stone
et al., 2004). In that study, no variation in the fibulin-5 gene
which caused an amino-acid change, was found among 429
control individuals from the United States. Individuals III: 2
and III: 3 in the Iranian pedigree (Figure 2), known by
sequencing to be heterozygous for n.679T4C, are both over
80 years old. They would not submit to an eye examination,
but both appeared to have no or minimal visual difficulties,
making it unlikely that they had age-related macular
T Y G P F I
Figure 1. DNA sequence analysis of the region surrounding the n.679T4C
mutation in proband. The site of mutated nucleotide and coded amino acids
are indicated.
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Figure 2. Pedigree of the cutis laxa family of Hamadan, Iran. The full
pedigree consists of 106 individuals.
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degeneration. It may be that some amino acid alterations
affect fibulin 5 functions not relevant to retinal morphology
and physiology. Alternatively, the genetic and environmental
backgrounds of the individuals may affect the penetrance of
the variations in relation to retinal function.
As all seven sequence variations found in the DNA of our
proband were homozygous, the haplotype defined by these
variations on the mutation-carrying FBLN5 allele can be
unambiguously described as Cn.945 XIVS9þ 137 GIVS9-218
AIVS10þ68 GIVS10-45, where the subscripts indicate positions
of nucleotides in the FBLN5 gene sequence (NT_026437) and
X refers to the altered GT tandem repeat sequence described
above. As the same haplotype was found on the n.679T4C-
carrying allele of the Turkish pedigree, it is probable that the
mutation in the two pedigrees had a common origin.
Identification of a haplotype associated with the fibulin-5
n.679T4C mutation will be useful in future investigations on
the gene and can help identify the origin of the mutation.
Diagnosis of carrier state is being offered to all young
members of the Iranian pedigree.
MATERIALS AND METHODS
Subjects
This study was performed after approval from the Ethics Review
Board of the National Institute for Genetic Engineering and
Biotechnology (Iran) and with informed consent of pedigree
members in accordance with The Declaration of Helsinki Principles.
The proband of the study belongs to a highly inbred pedigree whose
members have resided in Hamadan for at least five generations
(Figure 2). The pedigree has been previously described (Pour-Jafari
and Sarihi, 2004). The patient was originally identified at the age of
12, at which time she appeared prematurely aged. Her family
reported changed skin features, predominantly laxity of the skin,
from when she was 2 years old. They also reported umbilical hernia
and breathing difficulties during childhood. Her clinical features
were described in a Farsi article (Sarihi et al., 2004). Emphysema,
indications of supravalvular aortic stenosis, and a very hoarse voice
were among the features described. Light microscopy of skin biopsy
sections depicted normal dermis, but thin and atrophied epidermis.
Orcein Giemsa staining showed reduced and abnormal elastic
fibers. Her karyotype was normal (46,XX). The patient died at the age
of 14 and genetic studies were performed on cells of a skin fibroblast
cell line, which had been prepared.
The patient was diagnosed with cutis laxa before death. A male
sibling with similar abnormal skin features had died because of
pulmonary infections at the age of 2, and it was surmised that he was
also afflicted with cutis laxa. The existence of two afflicted siblings
who were children of a consanguineous marriage between
phenotypically normal individuals in a highly inbred pedigree
suggests an autosomal recessive mode of inheritance.
Linkage and mutation analysis
DNA of the proband was prepared from cultured skin fibroblast cells
and DNA of available members of the pedigree was extracted from
leukocytes. Linkage to fibulin-5 and ELNs was determined using
microsatellite markers located within 2 cM of the genes. Amplicons
containing the repeat sequences were amplified from the DNA of the
proband and her parents. Each of the 11 exons of the FBLN5 gene
and flanking intronic sequences of the proband’s DNA were
amplified by the PCR. In all, 9,509 nucleotides were sequenced,
including 167 nucleotides upstream of site of initiation of transcrip-
tion, the entire 50-untranslated, coding and 30-untranslated regions,
and 412 nucleotides downstream of the 30-end of the gene. More
limited sequencing was performed on the DNA of an affected
member of the previously reported Turkish pedigree, which had
kindly been put at our disposal.
Sequence variations were determined by comparison with the
NCBI genomic DNA reference sequences for the FBLN5 gene
NT_026437 and the FBLN5 mRNA NM_006329. The reference
numbers (rs#) of variations registered in build 124 of the NIH SNP
database (http://www.ncbi.nlm.nih.gov) are provided. Effects of
sequence changes on splicing were predicted by comparison with
known canonical splice site motifs (http://www.fruitfly.org/seq_-
tools/splice.html).
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